LG Household & Health Care Files Rhamnose Acetamide As A New Cosmetic Ingredient in China

Oct 27, 2026

Leave a message

news-1536-1024

Public Record Establishes the Ingredient's Filing Status

The filing identifies the ingredient by its Chinese name, rendered here as rhamnose acetamide. The October 27 entry records the ingredient name, the filing company, and the date, giving cosmetic developers a way to track future updates. The filing number is particularly useful when searching for the entry because LG Household & Health Care also filed a separate rhamnose-related ingredient, carboxymethyl rhamnoside, around the same time. The two materials appear under distinct records, so any specifications or subsequent status updates should be matched to the corresponding filing number.

 

Technical Disclosure Will Clarify the Material's Specifications

The initial announcement provided the ingredient name and filing details. Technical documentation would help laboratories establish the material's identity, determine how its content is measured, and compare samples from different lots. Relevant details could include the analytical method, assay limits, impurity profile, and physical form of the supplied material. Those details also affect how researchers interpret published work on related sugar derivatives. A meaningful comparison depends on identifying the material tested in each study and checking whether its composition and preparation match the ingredient being evaluated.

news-1536-1024

 

news-1536-1024

Formulation Research Can Evaluate Compatibility and Stability

Once a characterized sample is available, formulation teams can assess how rhamnose acetamide behaves in a selected cosmetic base. Early work could measure solubility or dispersion, track changes in pH and appearance, and check whether the ingredient remains stable during storage. Comparing a test formulation with an otherwise identical base would help isolate changes associated with adding the ingredient. Studies could also examine whether processing temperature or the order of addition affects the result. These are prospective formulation tests. The initial public disclosure did not provide performance results or a use concentration.

 

Safety Monitoring Is a Separate Regulatory Milestone

China's National Medical Products Administration provides for a three-year safety monitoring period for new cosmetic ingredients. During monitoring, the filing entity collects safety information and submits reports under the applicable rules. After the period ends, the technical assessment agency submits its opinion on whether the ingredient meets the relevant safety requirements. The initial disclosure for rhamnose acetamide recorded a completed filing and indicated that monitoring had yet to begin. The publication of technical requirements and any later update to monitoring status are therefore two separate milestones for this ingredient.

news-1536-1024

 

 

Send Inquiry